Literature DB >> 2970840

Propranolol and thyroxine-induced hypertrophic rabbit hearts: effect on heart size and regional O2 supply/consumption variables.

G J Grover1, J M Houghton, H R Weiss.   

Abstract

The purpose of this study was to determine the effect of acute and chronic propranolol on heart size and regional O2 supply/consumption variables in thyroxine (T4)-treated rabbit hearts. New Zealand white rabbits were given 0.5 mg/kg T4 for 3 or 16 days with and without concomitant 2 mg/kg propranolol. Another group was given 16 days of propranolol alone and another 3-day T4 group was given 2 mg/kg propranolol 1 h before the experiment began. Another group served as control. Myocardial blood flows were determined using radioactive microspheres and small arteriolar and venous O2 saturations were determined using microspectrophotometry. Treatment with T4 for 3 or 16 days increased the heart weight/body weight ratio, myocardial blood flow, and regional O2 consumption. 16-day T4 treatment resulted in myocardial flow 195% and O2 consumption 300% above control group values. When propranolol was given chronically along with T4, heart weight/body weight ratios did not increase to the degree seen with 3 or 16 days of T4, alone. Propranolol given acutely in 3-day T4-treated animals, resulted in a reduced O2 consumption and O2 extraction, though not to the extent seen with chronic propranolol treatment of T4-treated animals. Acute propranolol treatment slightly reduced myocardial blood flow in 3-day T4-treated animals, while chronic treatment significantly reduced it. Chronic propranolol treatment in 16-day T4-treated animals resulted in a significant reduction in flow and O2 consumption. Thus, T4 treatment increased O2 consumption, flow, and heart size and these effects could be attenuated using acute and chronic propranolol.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2970840     DOI: 10.1007/bf01907360

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  33 in total

1.  A correlation of clinical and hemodynamic studies in patients with hyperthyroidism with and without congestive heart failure.

Authors:  J S GRAETTINGER; J J MUENSTER; L A SELVERSTONE; J A CAMPBELL
Journal:  J Clin Invest       Date:  1959-08       Impact factor: 14.808

2.  Cardiovascular effects of thyroxine treatment in normal rats.

Authors:  M BEZNAK
Journal:  Can J Biochem Physiol       Date:  1962-12

3.  New tactics for hyperthyroidism: sympathetic blockade.

Authors:  M Riddle; T B Schwartz
Journal:  Ann Intern Med       Date:  1970-05       Impact factor: 25.391

4.  The enhanced myocardial contractility of thyrotoxicosis. Role of the beta adrenergic receptor.

Authors:  W Grossman; N I Robin; L W Johnson; H L Brooks; H A Selenkow; L Dexter
Journal:  Ann Intern Med       Date:  1971-06       Impact factor: 25.391

5.  Myocardial blood flow in experimental cardiac hypertrophy in dogs.

Authors:  G V Marchetti; L Merlo; V Noseda; O Visioli
Journal:  Cardiovasc Res       Date:  1973-07       Impact factor: 10.787

6.  Adrenaline-induced "oxygen-wastage" and enzyme release from working rat heart. Effects of calcium antagonism, beta-blockade, nicotinic acid and coronary artery ligation.

Authors:  L H Opie; F T Thandroyen; C Muller; O L Bricknell
Journal:  J Mol Cell Cardiol       Date:  1979-10       Impact factor: 5.000

7.  Thyroxine-induced changes in characteristics and activities of beta-adrenergic receptors and adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate systems in the heart may be related to reputed catecholamine supersensitivity in hyperthyroidism.

Authors:  J Tse; R W Wrenn; J F Kuo
Journal:  Endocrinology       Date:  1980-07       Impact factor: 4.736

8.  Cardiac failure in the dog as a consequence of exogenous hyperthyroidism.

Authors:  D Piatnek-Leunissen; R E Olson
Journal:  Circ Res       Date:  1967-02       Impact factor: 17.367

9.  Thyroid hormone regulation of beta-adrenergic receptor number.

Authors:  L T Williams; R J Lefkowitz; A M Watanabe; D R Hathaway; H R Besch
Journal:  J Biol Chem       Date:  1977-04-25       Impact factor: 5.157

10.  The influence of sympathetic nervous activity on regression of cardiac hypertrophy.

Authors:  B E Strauer; F Bayer; H M Brecht; W Motz
Journal:  J Hypertens Suppl       Date:  1985-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.